Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Net Income (Continuing Operations) : ¥1,330 Mil (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shanghai Shyndec Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ¥424 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,330 Mil.

Shanghai Shyndec Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co Net Income (Continuing Operations) Chart

Shanghai Shyndec Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

900.05

821.15

867.49

964.61

1,332.08

Shanghai Shyndec Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															425.86	461.03	312.56	132.63	423.54

Shanghai Shyndec Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,330 Mil.

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Shanghai Shyndec Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Shyndec Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

No.1320 Beijinxi Road, Shanghai, CHN, 200040

Website

http://www.shyndec.com

Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.

Executives

Li Hao	senior management
Ni Feng	Director
Li Xian Lin	senior management
Hao Chao Feng	senior management
Lian Wan Yong	Director
Han Yan Lin	Director
Yang Wen Ming	Supervisors
Feng Ming	Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines